Circulating Tumor DNA and Late Recurrence in High-Risk Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Breast Cancer | Zendy

Marla Lipsyc-Sharf | Zendy; Elza C. de Bruin | Zendy; Katheryn Santos | Zendy; Robert McEwen | Zendy; Daniel Stetson | Zendy; Ashka Patel | Zendy; Gregory J. Kirkner | Zendy; Melissa E. Hughes | Zendy; Sara M. Tolaney | Zendy; Ann H. Partridge | Zendy; Ian E. Krop | Zendy; Charlene Knape | Zendy; Ute Feger | Zendy; Giovanni Marsico | Zendy; Karen Howarth | Zendy; Eric P. Winer | Zendy; Nancy U. Lin | Zendy; Heather A. Parsons | Zendy

Open Access

Circulating Tumor DNA and Late Recurrence in High-Risk Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Breast Cancer

Author(s) -

Marla Lipsyc-Sharf,

Elza C. de Bruin,

Katheryn Santos,

Robert McEwen,

Daniel Stetson,

Ashka Patel,

Gregory J. Kirkner,

Melissa E. Hughes,

Sara M. Tolaney,

Ann H. Partridge,

Ian E. Krop,

Charlene Knape,

Ute Feger,

Giovanni Marsico,

Karen Howarth,

Eric P. Winer,

Nancy U. Lin,

Heather A. Parsons

Publication year - 2022

Publication title -

journal of clinical oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 10.482

H-Index - 548

eISSN - 1527-7755

pISSN - 0732-183X

DOI - 10.1200/jco.22.00908

Subject(s) - medicine , breast cancer , oncology , cancer , minimal residual disease , hormone receptor , primary tumor , stage (stratigraphy) , prospective cohort study , metastasis , paleontology , leukemia , biology

To examine the prevalence and dynamics of circulating tumor DNA (ctDNA) and its association with metastatic recurrence in patients with high-risk early-stage hormone receptor-positive breast cancer (HR+ BC) more than 5 years from diagnosis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research